These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IGK AND Treatment
15 results:

  • 1. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
    Leongamornlert D; Gutiérrez-Abril J; Lee S; Barretta E; Creasey T; Gundem G; Levine MF; Arango-Ossa JE; Liosis K; Medina-Martinez JS; Zuborne Alapi K; Kirkwood AA; Clifton-Hadley L; Patrick P; Jones D; O'Neill L; Butler AP; Harrison CJ; Campbell P; Patel B; Moorman AV; Fielding AK; Papaemmanuil E
    Blood Adv; 2023 Aug; 7(15):3862-3873. PubMed ID: 36867579
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia.
    Mai H; Li Q; Wang G; Wang Y; Liu S; Tang X; Chen F; Zhou G; Liu Y; Li T; Wang L; Wang C; Wen F; Liu S
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3259-3266. PubMed ID: 35918464
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CAR T cells targeting options in the fight against multiple myeloma.
    Nicolini F; Bravaccini S; Mazza M; Gruszka AM; Tazzari M; MartÍn-Antonio B; Juan M; Ibrahim T; Maltoni R; Martinelli G; Cerchione C
    Panminerva Med; 2021 Mar; 63(1):37-45. PubMed ID: 32955187
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Richter's syndrome of the central nervous system diagnosed concurrently with chronic lymphocytic leukaemia: A case report and literature review.
    Xu L; Song JC; Sun XH; Gao ZF; Lv L; Zhu J
    Medicine (Baltimore); 2018 Oct; 97(41):e12701. PubMed ID: 30313065
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements.
    Besbes S; Hamadou WS; Boulland ML; Youssef YB; Achour B; Regaieg H; Khelif A; Fest T; Soua Z
    Braz J Med Biol Res; 2017 Jan; 50(1):e5426. PubMed ID: 28099581
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combined IKZF1 and IG markers as new tools for diagnosis and minimal residual disease assessment in Tunisian B-ALL.
    Besbes S; Hamadou WS; Boulland ML; Lefranc MP; Ben Youssef Y; Achour B; Khelif A; Fest T; Soua Z
    Bull Cancer; 2016 Oct; 103(10):822-828. PubMed ID: 27614734
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Application of Combined Detection of Fusion Gene and BIOMED-2 Standardized Ig Gene Rearrangement System in Childhood B-cell Acute Lymphoblastic leukemia].
    Ai XF; Zhang Y; Shi XR; Zheng YC; Zhang L; Wang XJ; Li QH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):352-7. PubMed ID: 27150991
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.
    Logan AC; Vashi N; Faham M; Carlton V; Kong K; Buño I; Zheng J; Moorhead M; Klinger M; Zhang B; Waqar A; Zehnder JL; Miklos DB
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1307-13. PubMed ID: 24769317
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Study of immunoglobulin and T-cell receptor gene rearrangements in patients with non-Hodgkin's lymphoma].
    Wu RQ; Qiao C; Tong Y; Ge Z; Zhang JF; Wu YJ; Qiu HR; Wang Z; Liu P
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):10-5. PubMed ID: 22575185
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. BCL2 and MYC dual-hit lymphoma/leukemia.
    Tomita N
    J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tracing the pre-B to immature B cell transition in human leukemia cells reveals a coordinated sequence of primary and secondary igk gene rearrangement, igk deletion, and IGL gene rearrangement.
    Klein F; Feldhahn N; Mooster JL; Sprangers M; Hofmann WK; Wernet P; Wartenberg M; Müschen M
    J Immunol; 2005 Jan; 174(1):367-75. PubMed ID: 15611260
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
    Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
    Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia.
    Bierings M; Szczepański T; van Wering ER; Willemse MJ; Langerak AW; Révész T; van Dongen JJ
    Br J Haematol; 2001 Jun; 113(3):757-62. PubMed ID: 11380467
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
    Nakao M; Janssen JW; Flohr T; Bartram CR
    Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.
    Pongers-Willemse MJ; Verhagen OJ; Tibbe GJ; Wijkhuijs AJ; de Haas V; Roovers E; van der Schoot CE; van Dongen JJ
    Leukemia; 1998 Dec; 12(12):2006-14. PubMed ID: 9844931
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.